SAFECARE BIOTECH (HANGZHOU) CO., LTD – Trademark Portfolio

Entity Type: 16

SAFECARE BIOTECH (HANGZHOU) CO., LTD holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include FF and FIRSTVIEW. The owner is based in Hangzhou, Zhejiang.

Room 203, Building 2, No. 18 Haishu Road

Cangqian Street, Yuhang District

Hangzhou, Zhejiang 311100 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

FF
FF
Registered 2021
FIRSTVIEW
FIRSTVIEW
Registered 2020

Trademark Classifications

SAFECARE BIOTECH (HANGZHOU) CO., LTD's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does SAFECARE BIOTECH (HANGZHOU) CO., LTD have?

SAFECARE BIOTECH (HANGZHOU) CO., LTD has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does SAFECARE BIOTECH (HANGZHOU) CO., LTD file in?

SAFECARE BIOTECH (HANGZHOU) CO., LTD files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are SAFECARE BIOTECH (HANGZHOU) CO., LTD's most well-known trademarks?

SAFECARE BIOTECH (HANGZHOU) CO., LTD's registered trademark portfolio includes well-known marks such as FF and FIRSTVIEW. These are among 2 currently registered trademarks in the portfolio.

What is SAFECARE BIOTECH (HANGZHOU) CO., LTD's trademark registration success rate?

SAFECARE BIOTECH (HANGZHOU) CO., LTD has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.